glp 1 rash from a GLP-1 explained by an allergist 👆, Thanks to my friend @rubin_allergy for the information in this video Exploring Semaglutide-Induced Rash: Causes, Prevention,

Description

Clinical Significance If approved, orforglipron would be the first oral medication specifically approved for chronic weight management that activates the GLP-1 receptor without requiring injection, absorption enhancers, or dietary restrictions

In the ATTAIN-MAINTAIN trial, orforglipron's profile was "consistent with previous orforglipron Phase 3 studies." The most common adverse events were gastrointestinal-related and were generally mild-to-moderate in severity, which is expected for the GLP-1 class

Final Thoughts on GLP-1 Therapy for Men Chicago Weight loss does not have to come at the expense of strength, energy, or confidence

This supports the development of peptides with longer half-lives and better resistance to enzymatic breakdown

Key findings from the new studies: ARTIOS trial: Patients who switched to Kesimpta after experiencing relapses or MRI activity on other oral treatments showed fewer relapses, suppressed MRI activity, and over 90% achieved no evidence of disease activity (NEDA-3)